Central Mass. Practices Among NECC Customers, FDA Says

  • Comment
The FDA recently announced that several local medical practices purchased products from the NECC, which is believed to have caused a recent multi-state meningitis outbreak.
The FDA recently announced that several local medical practices purchased products from the NECC, which is believed to have caused a recent multi-state meningitis outbreak. Photo Credit: File photo

SOUTHBOROUGH, Mass. — A list of customers of the Framingham drug company believed to be responsible for a nationwide meningitis outbreak includes practices in Southborough and Westborough, according to the FDA.

Earlier this month, the FDA advised medical professionals to stop using products from the New England Compounding Center (NECC) after steroids made by the company were linked to the outbreak which has infected more than 320 people and killed 24.

According to a list updated on Wednesday, the Southborough Medical Group and America’s Vein Center in Southborough were among those who purchased products from the NECC, as were the Keamy Eye & Laser Centre and Reliant Medical Group in Westborough.

None of the practices purchased the steroids that are believed to have caused the outbreak. However, state officials investigating of the NECC found “serious health and safety deficiencies related to the practice of pharmacy,” according to a preliminary report released on Oct. 23. As such, the FDA is advising health care providers to follow up with patients who received any injectable NECC product on or after May 21, 2012.

The full list of nationwide customers includes regional practices like the MetroWest Regional Medical Center in Framingham, the Milford Regional Medical Center in Milford and the UMass Memorial Medical Center in Worcester. For a complete list of nationwide customers and the NECC products they purchased, click here.

  • Comment

Comments